kalbitor(Ecallantide)Medication DetailsTakeda Pharmaceuticals America, Inc.Usage: KALBITOR (ecallantide) is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in patients aged 12 and older.Medication Details
takhzyro(lanadelumab-flyo)Medication DetailsTakeda Pharmaceuticals America, Inc.Usage: TAKHZYRO® is indicated for the prophylaxis of hereditary angioedema (HAE) attacks in adults and pediatric patients aged 2 years and older.Medication DetailsDrug Interactions